Candriam S.C.A. Legend Biotech Corp Transaction History
Candriam S.C.A.
- $16.3 Billion
- Q2 2024
A detailed history of Candriam S.C.A. transactions in Legend Biotech Corp stock. As of the latest transaction made, Candriam S.C.A. holds 261,035 shares of LEGN stock, worth $12.9 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
261,035
Previous 221,032
18.1%
Holding current value
$12.9 Million
Previous $12.4 Million
6.74%
% of portfolio
0.07%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding LEGN
# of Institutions
198Shares Held
74.2MCall Options Held
374KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$566 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$370 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$327 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$282 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$235 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $8.25B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...